首页 > 市场调查报告书 > 食物/饮料

食品添加剂

市场调查报告书

商品编码

1423448

全球低聚果糖市场 - 2023-2030

Global Fructo-Oligosaccharides Market - 2023-2030

出版日期: 2024年02月09日 | 出版商:

DataM Intelligence | 英文 171 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年全球低聚果糖市场规模达32.1亿美元，预计2030年将达到59.9亿美元，2023-2030年预测期间CAGR为8.1%。

低聚果糖甜度低，不致龋，可作为可溶性膳食纤维。该产品的低热量特性促使其作为糖替代品应用于各种食品和非食品领域，例如婴儿配方奶粉、食品和饮料、膳食补充剂、动物饲料和药品。本产品有固体、液体两种形式，或可方便有效地应用于所需的产品中。

产品的各种功能优势推动了产品的更多生产需求。製造商在产品製造中采用永续实践正在扩大全球市场的正面影响力。製造商正在投资绿色化学，作为低能源强度和零排放永续发展承诺的一部分。例如，塔塔化学品有限公司开发了一种发酵平台，这是一种从糖生产低聚果糖的技术。

北美主导了市场成长。根据美国疾病管制与预防中心 (CDC) 统计，约有 3,730 万美国人患有糖尿病，约占美国人口的 11.3%。生活方式障碍的日益流行正在提高消费者的健康意识，推动北美地区对糖替代品的需求，并对市场成长产生积极影响。

动力学

低聚果糖的功能优势

低聚果糖是非致龋性的，它们被用作可溶性膳食纤维。它们是可溶性膳食纤维的良好来源，可促进减少或消除便秘。它们还可以透过抑制与食物中毒相关的有毒细菌来支持消化道中健康细菌的生长。

低聚果糖不可消化，可以完整地通过小肠到达结肠，在那里它们支持健康细菌的生长，从而有助于维持适当的消化健康。低聚果糖用作益生元补充剂的成分。低聚果糖具有有益的生理作用，例如改善矿物质吸收。

大量使用低聚果糖作为替代糖

根据世界卫生组织2022年统计，全球有超过10亿人患有肥胖症，其中6.5亿人是成年人，3.4亿人是青少年。儿童肥胖的严重程度也在增加，根据世界卫生组织的统计，2022 年儿童肥胖人数高达 3,900 万人。

根据 IDF 2021 年糖尿病图谱，全球有 5.37 亿成年人患有糖尿病。该组织报告称，肥胖症和糖尿病的盛行率正在迅速增加，预计到2030 年将达到6.43 亿。由于高热量消费，全球肥胖和糖尿病盛行率不断增加，因此对低热量替代甜味剂的需求更大。

低聚果糖主要用作低热量的替代甜味剂。它们味道细腻香甜，热量低，提供的热量不到蔗糖的一半。这些低聚果糖不易消化，因此不会影响血糖值。它们被用于各种食品应用，作为推动市场成长的替代糖。

低聚果糖的高成本和潜在副作用

低聚果糖的高成本可能是全球市场成长的主要限制因素之一。较低的产量、较高的生产成本、复杂的纯化和品质控制是导致低聚果糖成本较高的一些因素。对价格敏感的最终用户可能会采用其他更便宜的糖替代品，而放弃该产品。

过度使用低聚果糖可能会导致一些潜在的副作用，例如腹泻、腹胀和胃痉挛。副作用也可能是由于果糖不耐症造成的。大量使用会导致胃部不适并伤害肠躁症患者。

Fructo-oligosaccharides have a low sweetness intensity, non-cariogenic and used as soluble dietary fibres. The low-calorie nature of the product drives its use as a sugar alternative for applications in various categories of food and non-food segments such as infant formulation, food & beverages, dietary supplements, animal feed and pharmaceuticals. The product is available in solid in liquid form or its convenient and effective application in required products.

Various functional benefits of the product drive the product demand for more production. The adoption of sustainable practices by manufacturers for product manufacturing is expanding the positive reach of the market at the global level. Manufacturers are investing in Green Chemistry as part of the sustainability commitment to low energy intensity and zero effluents. For instance, TATA Chemicals Limited developed a Fermentation Platform, a technology to produce fructo-oligosaccharides from sugar.

North America dominated the market growth. According to the CDC, about 37.3 million Americans are suffering from diabetes, covering about 11.3 % of the United States population. The increasing prevalence of lifestyle disorders is raising the health consciousness among consumers driving the need for sugar alternatives in North America, and positively impacting market growth.

Dynamics

Functional Benefits of Fructo-Oligosaccharides

Fructo-oligosaccharides are non-cariogenic, they are set to be used as soluble dietary fibers. They are good sources of soluble, dietary fiber and promote the reduction or elimination of constipation. They also support the growth of healthy bacteria in the digestive tract by suppressing toxic bacteria associated with food poisoning.

Fructo-oligosaccharides are non-digestible and travel intact through the small intestine to the colon, where they support the growth of healthy bacteria which help in maintaining proper digestive health. Fructo-oligosaccharides are used as an ingredient in prebiotic supplements. Fructo-oligosaccharides have beneficial physiological effects such as improved mineral absorption.

High Use of Fructo-Oligosaccharides as an Alternative Sugar

According to the World Health Organization 2022 statistics, more than 1 billion people globally are suffering from obesity, where 650 million people are adults and 340 million are adolescents. The severity of obesity is increasing in children too, accounting for up to 39 million according to 2022, WHO statistics.

According to IDF Diabetes Atlas 2021, 537 million adults are living with diabetes in the world. The organization reports that the prevalence is increasing rapidly and is estimated to reach 643 million by 2030. With the increasing prevalence of obesity and diabetes globally due to high-calorie consumption, there is a greater need for low-calorie, alternative sweeteners.

Fructo-oligosaccharides are used primarily as a low-calorie, alternative sweetener. They are delicate sweet flavor has low calories, and provide less than half the caloric value of sucrose. These fructooligosaccharides are non-digestible, so they don't affect blood sugar levels. These are used in various food applications as an alternative sugar driving market growth.

High Cost and Potential Side Effects of the Fructo-Oligosaccharides

The high cost of fructo-oligosaccharides can be one of the major restraining factors for global market growth. The lower yield, high production costs, complex purification and quality control are some of the factors that contribute to the high cost of the fructo-oligosaccharides. The price-sensitive end-users may take up other alternative less expensive sugar alternatives, leaving the product behind.

The overuse of fructo-oligosaccharides may cause some of the potential side effects such as diarrhea, bloating and stomach cramps. The side effects can also be due to the which can be fructose intolerance. The high use can lead to gastric distress and hurt people with irritable bowel syndrome.

Segment Analysis

The global fructo-oligosaccharides market is segmented based on source, form, application and region.

High Demand for Low-Calorie Food and Beverage Products

The global fructo-oligosaccharides market is segmented based on application into infant formulation, food & and beverages, dietary supplements, animal feed, and pharmaceuticals. Food and beverage accounted for the largest share of the global market due to increased demand for low-calorie food products. With the increasing health concerns related to high-sugar products, there is a surge in demand for sugar alternatives for their use in the production of low-calorie food and beverages.

The fructo-oligosaccharides have multiple applications in the food and beverage sectors such as confectionery, bakery, beverages, desserts and others. The new product launch for their application in the food and beverages sectors drives the segment growth. For instance, in May 2023, BENEO, the company that offers naturally sourced, functional ingredients announced the launch of Beneo-scL85 ingredients for sugar reduction. These ingredients are actively used in various food applications such as bakery, dairy, and cereals.

Geographical Penetration

Increasing Demand for Low-Calorie Products In North America

North America dominated the global fructo-oligosaccharides market. With the increasing health consciousness among consumers, there is a greater need for healthy alternatives for various food products in this region. The region has an increased prevalence of obesity and diabetes driving the need for alternative sugar products for its use in multiple food product manufacturing.

According to the Centers for Disease Control and Prevention 2023, obesity affects over 41.9 % of adults and 19.7 % of children in the United States. The American Heart Association recommends the strict restriction of less than 100 sugar calories per day for most adult women and less than 150 sugar calories per day for most men, motivating consumers to take low-calorie products, and increasing the demand for sugar alternatives.

Competitive Landscape

The major global players in the market include BENEO, Cargill, Incorporated, Ingredion, Tereos, Biosynth, Tate & Lyle, Galam Group, TATA Chemicals Limited, AVANSCHEM and Merck KGaA.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic had a positive impact on the global fructo-oligosaccharides market. Even though the pandemic created greater challenges for the market manufacturers in the production and distribution of the product to the end-user due to interrupted supply chain activities, the market then increased its sales through the use of e-commerce platforms and high demand from the end-use industries.

According to NIH 2020, obesity and diabetes are two major risk factors for COVID-19 hospitalization. The organization stated that people with diabetes mellitus and severe obesity are more likely to get infected and are at a higher risk of mortality from COVID-19. Among elderly patients who are at higher risk of death from COVID-19, 26.8% have diabetes mellitus. To maintain their calorie intake, increased consumer preference towards low-calorie products.

By Source

Sucrose
Inulin

By Form

Liquid
Powder

By Application

Infant Formulation
Food & Beverages
Dietary Supplements
Animal Feed
Pharmaceuticals

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In May 2023, BENEO, the company that offers naturally sourced, functional ingredients announced the launch of Beneo-scL85 ingredients for sugar reduction. These ingredients are actively used in various food applications such as bakery, dairy, and cereals.
In March 2022, Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions, signed the agreement to acquire Quantum Hi-Tech Biological Co. Ltd, the company that is involved in the production and marketing of fructo-oligosaccharides.
In June 2020, Galam, the global nutrition ingredients manufacturer of specialty ingredients for the food and animal nutrition industries, incorporated two new fructooligosaccharides production plants with an investment of about USD 20 million.

Why Purchase the Report?

To visualize the global fructo-oligosaccharides market segmentation based on source, form, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of fructo-oligosaccharides market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global fructo-oligosaccharides market report would provide approximately 62 tables, 52 figures and 171 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Source
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Functional Benefits of Fructo-Oligosaccharides
  - 4.1.1.2. High Use as an Alternative Sugar
- 4.1.2. Restraints
  - 4.1.2.1. High Cost and Potential Side Effects of the Fructo-Oligosaccharides
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Sucrose
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Inulin

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Liquid
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Powder

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Infant Formulation
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Food & Beverages
9.4. Dietary Supplements
9.5. Animal Feed
9.6. Pharmaceuticals

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. BENEO
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Cargill, Incorporated
12.3. Ingredion
12.4. Tereos
12.5. Biosynth
12.6. Tate & Lyle
12.7. Galam Group
12.8. TATA Chemicals Limited
12.9. AVANSCHEM
12.10. Merck KGaA

LIST NOT EXHAUSTIVE